Amiodarone IV (ACLS & ICU Infusion)
AHA ACLS bolus dosing, syringe pump maintenance infusion (6 mg/mL), and phlebitis and arrhythmia surveillance protocol.
AHA ACLS Quick Reference (Adult)
Cardiac Arrest: Shock-Refractory VF / pVT
Adult Cardiac Arrest Algorithm. Amiodarone or lidocaine may be considered when VF/pVT persists despite defibrillation; the algorithm places the first antiarrhythmic dose after the third shock.
2nd dose: 150 mg IV/IO bolus
- Give as a rapid push during CPR, followed by a 20 mL flush; IV access is attempted first, IO if IV is not achievable.
- Never interrupt chest compressions or delay defibrillation to give amiodarone.
- Lidocaine alternative: 1–1.5 mg/kg, then 0.5–0.75 mg/kg.
Tachycardia With a Pulse: Stable Wide-QRS
Adult Tachyarrhythmia With a Pulse Algorithm. If the patient is unstable (hypotension, altered mental status, shock, ischemic chest pain, acute heart failure), perform synchronized cardioversion first.
- Repeat 150 mg over 10 minutes if VT recurs.
- Follow with maintenance infusion: 1 mg/min for 6 hours, then 0.5 mg/min.
- Procainamide or sotalol are listed alternatives; expert consultation is advised.
Source: 2025 American Heart Association Guidelines for CPR and Emergency Cardiovascular Care, Part 9: Adult Advanced Life Support, and the 2025 ACLS algorithms. Always check local resuscitation policy.
Syringe Pump Maintenance Infusion (Standard Concentration)
| Ampoule Presentation | 3 mL ampoule (50 mg/mL = 150 mg of amiodarone hydrochloride) |
|---|---|
| Amiodarone Dose | 300 mg (6 mL = two 3 mL ampoules) |
| Compatible Diluent | 44 mL of 5% Dextrose (D5W) only |
| Final Syringe Volume | 50 mL |
| Final Concentration | 6 mg/mL (central line) |
| Stability | 24 hours at room temperature in a polypropylene syringe |
Materials Required
- Amiodarone ampoules 50 mg/mL (3 mL) × 2
- 60 mL Luer-lock syringe (polypropylene)
- 5% Dextrose (D5W)
- Sterile drawing-up needle / filter needle
- Dedicated syringe pump infusion label
- Non-PVC (DEHP-free) extension line (100 cm)
- Alcohol chlorhexidine swabs
Bolus & Loading Dose Preparation
| Cardiac Arrest Bolus | 300 mg (6 mL) drawn up undiluted, or diluted to 20 mL with D5W, given as rapid IV/IO push. Second dose 150 mg (3 mL) prepared the same way. |
|---|---|
| Loading Dose (Central Line) | 150 mg (3 mL) diluted with D5W to 20 mL (7.5 mg/mL), infused over 10 minutes at 120 mL/hr. |
| Loading Dose (Peripheral Line) | 150 mg (3 mL) in 100 mL D5W (1.5 mg/mL), infused over 10 minutes via a large peripheral vein. |
Preparation Procedure (Aseptic Non-Touch Technique)
- Verification: Verify the written physician order, patient identity, indication, and baseline heart rate, blood pressure, rhythm, and QTc. During cardiac arrest, follow verbal orders with closed-loop communication.
- Hand Hygiene: Perform thorough hand hygiene and clean preparation workspace.
- Ampoule Check: Check each amiodarone ampoule for:
- Correct drug and strength, amiodarone hydrochloride (50 mg/mL)
- Expiry date
- Container integrity, clarity, and absence of precipitate
- Withdrawal: Open two ampoules of amiodarone. Withdraw 3 mL from each ampoule into a 60 mL Luer-lock syringe (Total amiodarone drawn: 6 mL = 300 mg amiodarone). The solution is viscous; draw up slowly.
- Dilution: Add 44 mL of 5% Dextrose to a final volume of 50 mL. Do not dilute with 0.9% Sodium Chloride.
- Mixing: Gently invert the syringe several times; avoid vigorous shaking, which causes foaming.
- Visual Inspection: Inspect solution to ensure it is clear, pale yellow, and free of visible particles or precipitate.
- Labeling & Dual Verification: Apply infusion label and obtain an independent double-check by another registered nurse.
- Syringe Pump Setup: Prime a non-PVC extension set and install into the syringe pump.
🔒 Lumen Policy: Amiodarone is incompatible with numerous drugs, including heparin and sodium bicarbonate. Infuse via a dedicated central venous catheter lumen. It leaches plasticizer (DEHP) from PVC, so use non-PVC tubing for infusions lasting longer than 2 hours.
⚠️ Peripheral Administration: Concentrations above 2 mg/mL cause phlebitis and require a central line. If only peripheral access is available, use a large proximal vein and a concentration of 2 mg/mL or less (for example, 900 mg in 500 mL D5W = 1.8 mg/mL).
Electrophysiological Profile
Amiodarone is classified as a Class III antiarrhythmic, but it also has Class I, II, and IV actions. This broad profile explains both its effectiveness and its adverse effects.
Class III (Potassium Channel)
- Prolongs repolarization and action potential duration
- Lengthens the QT interval
Class II & IV (β and Calcium)
- Slows sinus rate and AV nodal conduction
- Useful for ventricular rate control in atrial fibrillation
IV Formulation Effect
- Hypotension is the most common acute adverse effect of IV dosing
- Related to infusion rate; slow the infusion if it occurs
Administration & 24-Hour Infusion Regimen
Recommended Dosing Parameters (Patient With a Pulse)
- Rapid Loading: 150 mg over 10 minutes (15 mg/min).
- Rapid Maintenance: 1 mg/min for 6 hours (360 mg) = 10 mL/hr of the 6 mg/mL syringe.
- Slow Maintenance: 0.5 mg/min for 18 hours (540 mg) = 5 mL/hr.
- Breakthrough VT/VF: Supplemental 150 mg over 10 minutes may be repeated.
- Maximum Dose: 2.2 g in 24 hours (all IV doses combined).
- After Cardiac Arrest: Following ROSC, a maintenance infusion may be started on clinician order using the same regimen.
- Beyond 24 Hours: Continue 0.5 mg/min or convert to oral therapy as directed.
- Syringe Continuity: At 10 mL/hr a 50 mL syringe lasts 5 hours. Prepare the next syringe in time; it may be made up a maximum of 1 hour in advance and labelled clearly with contents and expiry.
- Discard Policy: Discard 24 hours after preparation or earlier if the solution becomes cloudy, precipitated, or contaminated.
Monitoring Requirements
- Continuous ECG monitoring for bradycardia, AV block, and QTc prolongation; record QTc at baseline and regularly during infusion.
- Monitor blood pressure frequently during loading (arterial line preferred in the ICU).
- Keep serum potassium and magnesium in the normal range.
- Check liver function and thyroid function at baseline and during continued therapy.
- Inspect the infusion site regularly for phlebitis (pain, erythema, induration).
Contraindications & Cautions
- Contraindicated (non-arrest settings): Cardiogenic shock, marked sinus bradycardia, and second- or third-degree AV block without a functioning pacemaker.
- QT-Prolonging Drugs: Additive risk of torsades de pointes; review all concurrent medications.
- Interactions: Raises digoxin and warfarin effect; dose reduction and closer monitoring are usually needed.
- Hypersensitivity: Known allergy to amiodarone or iodine.
Phlebitis & Extravasation Response Protocol
Amiodarone is an irritant; concentrated solutions cause phlebitis, and extravasation can lead to skin necrosis.
Normal Infusion Site
- No erythema or streaking along the vein
- No local swelling or induration
- No pain, burning, or stinging
- No tissue discolouration
Phlebitis or Extravasation Suspected:
- STOP infusion immediately (do not flush line).
- Notify clinician promptly and arrange alternative (preferably central) access.
- Aspirate residual drug through the cannula if possible, then remove catheter.
- Elevate the limb and manage per local extravasation policy.
- Document event in patient clinical record.
Amiodarone Infusion Rate Chart (6 mg/mL)
Amiodarone infusions are dosed in mg/min, independent of weight. Shows the pump rate for each dose and the amount delivered per hour and per 24 hours.
| Dose (mg/min) |
Pump Rate (mL/hr) |
Delivered (mg/hr) |
If Continued 24 hr (mg) |
Standard Regimen Phase |
|---|---|---|---|---|
| 0.25 | 2.5 | 15 | 360 | — |
| 0.5 | 5 | 30 | 720 | Slow maintenance (hours 7–24) |
| 0.75 | 7.5 | 45 | 1080 | — |
| 1 | 10 | 60 | 1440 | Rapid maintenance (hours 1–6) |
First 24 Hours: Standard Regimen Summary
| Phase | Dose | Duration | Drug Delivered | Rate |
|---|---|---|---|---|
| Rapid loading | 150 mg | 10 min | 150 mg | 120 mL/hr (20 mL syringe) |
| Rapid maintenance | 1 mg/min | 6 hr | 360 mg | 10 mL/hr (6 mg/mL) |
| Slow maintenance | 0.5 mg/min | 18 hr | 540 mg | 5 mL/hr (6 mg/mL) |
| Total | 24 hours | 1,050 mg | Maximum 2.2 g / 24 hr including boluses | |
Infusion Conversion (Solution Concentration 6 mg/mL)
Standard equations for a 6 mg/mL solution (300 mg in 50 mL):
Rate (mL/hr) = [ Dose (mg/min) × 60 ] / 6
Shortcut: Rate = Dose × 10
Dose (mg/min) = [ Rate (mL/hour) × Concentration (6 mg/mL) ] / 60
Shortcut: Dose = Rate ÷ 10
Worked example: 1 mg/min → 1 × 10 = 10 mL/hr; 0.5 mg/min → 5 mL/hr.